ARYA SCIENCES ACQU CORP IV's ticker is ARYD and the CUSIP is G31659108. A total of 56 filers reported holding ARYA SCIENCES ACQU CORP IV in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,040,000 | +1.9% | 400,000 | 0.0% | 0.21% | -9.9% |
| Q3 2022 | $3,964,000 | +1.0% | 400,000 | 0.0% | 0.23% | -6.8% |
| Q2 2022 | $3,924,000 | +0.2% | 400,000 | 0.0% | 0.25% | +0.4% |
| Q1 2022 | $3,916,000 | -1.4% | 400,000 | 0.0% | 0.25% | +58.0% |
| Q4 2021 | $3,972,000 | -1.3% | 400,000 | 0.0% | 0.16% | +25.6% |
| Q3 2021 | $4,024,000 | -6.2% | 400,000 | 0.0% | 0.12% | -12.6% |
| Q2 2021 | $4,288,000 | +3.1% | 400,000 | 0.0% | 0.14% | -30.2% |
| Q1 2021 | $4,160,000 | – | 400,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 700,000 | $7,331,000 | 2.49% |
| Soleus Capital Management, L.P. | 300,000 | $3,142,000 | 0.57% |
| HealthCor Management, L.P. | 1,159,360 | $12,141,000 | 0.43% |
| Bain Capital Life Sciences Investors, LLC | 700,000 | $7,331,000 | 0.42% |
| SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $5,200,000 | 0.40% |
| Boxer Capital, LLC | 750,000 | $10,335,000 | 0.35% |
| Union Square Park Capital Management, LLC | 100,500 | $1,052,000 | 0.35% |
| Altium Capital Management LP | 100,000 | $1,047,000 | 0.29% |
| Consonance Capital Management LP | 250,000 | $2,618,000 | 0.28% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,000,000 | $10,473,000 | 0.23% |